Recursion Pharmaceuticals Inc vs Southern Copper Corp — how do they compare? Recursion Pharmaceuticals Inc trades at $3.38 (market cap $1.81B), while Southern Copper Corp trades at $197.1 (market cap $164.21B). The key difference: Southern Copper Corp is far larger — about 90.7× Recursion Pharmaceuticals Inc's market cap, and Southern Copper Corp pays a 2.26% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | SCCO | |
|---|---|---|
Market Cap | $1.81B | $164.21B |
Sector | Health | Basic Materials |
52-Week High | $6.79 | $218.85 |
52-Week Low | $2.84 | $93.70 |
Enterprise Value | $1.33B | $165.50B |
Dividend Yield | — | 2.26% |
Trailing returns across standard periods
Latest headlines on both assets
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →